Hydralazine Hydrochloride 43066-0041
Product NDC
43066-0041- Manufacturer
- Baxter Healthcare Corporation
- Dosage Form
- Injection
- Route
- Intramuscular And Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- July 17, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA219797
Need to source Hydralazine Hydrochloride? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Hydralazine Hydrochloride | 20 mg/mL |
Drug Class
Arteriolar Vasodilation [PE]Arteriolar Vasodilator [EPC]
Packaging Options(1)
25 VIAL, SINGLE-DOSE in 1 CARTON (43066-041-25) / 1 mL in 1 VIAL, SINGLE-DOSE (43066-041-01)